Coya Therapeutics
COYA

Coya Therapeutics (COYA) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$0.36
EPS estimate
−$0.42
Revenue
$163,616.00
Revenue estimate
$783,333.00
Reported
Aug 12, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 12, 2025−$0.42−$0.36+14.02%$163,616.00SEC
Q1 2025May 13, 2025−$0.19−$0.44−127.04%$300,000.00SEC
Q4 2024Mar 18, 2025−$0.28−$0.18+34.64%$1,000.00SEC
Q3 2024Nov 6, 2024−$0.36−$0.26+28.22%$0.00SEC
Q2 2024Aug 12, 2024−$0.17−$0.19−11.76%$3.4MSEC
Q1 2024May 9, 2024−$0.30−$0.35−16.67%$100,000.00SEC
Q4 2023Mar 19, 2024$0.26$0.14−45.59%$6.0MSEC
Q3 2023Nov 8, 2023−$0.35−$0.34+3.46%$0.00SEC
Q2 2023Aug 8, 2023−$0.32−$0.31+3.19%$0.00SEC
Q1 2023May 10, 2023−$0.43−$0.28+34.88%$0.00SEC
Q4 2022Mar 29, 2023$0.00−$0.24+0.00%$0.00SEC

Quarterly revenue

Q4 2022
$0.00
Q1 2023
$0.00
Q2 2023
$0.00
Q3 2023
$0.00
Q4 2023
$6.0M
Q1 2024
$100,000.00
Q2 2024
$3.4M
Q3 2024
$0.00
Q4 2024
$1,000.00
Q1 2025
$300,000.00
Q2 2025
$163,616.00

Frequently asked questions

  • When did Coya Therapeutics (COYA) last report earnings?

    Coya Therapeutics last reported on Aug 12, 2025, covering fiscal Q2 2025.

  • Did COYA beat earnings estimates?

    Yes. Coya Therapeutics reported EPS of −$0.36 for Q2 2025 against a −$0.42 estimate — a 14.02% beat.

  • How much revenue did COYA report last quarter?

    Coya Therapeutics reported $163,616.00 in revenue for Q2 2025, against a consensus estimate of $783,333.00.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.